Coronary calcium scores may help predict risk of death in patients without family history of heart disease

April 4, 2014 by Jennifer Johnson Mcewen
Coronary calcium scores may help predict risk of death in patients without family history of heart disease
Current guidelines only recommend coronary artery calcium (CAC) scoring for low-risk patients if they have a family history of early heart disease.

(Medical Xpress)—A new Emory University study shows that coronary artery calcium (CAC) scoring, a type of low-dose CT scan, accurately predicts the risk of dying over the next 15 years in patients with and without a family history of early heart disease. The findings were presented this week at the American College of Cardiology meeting in Washington, D.C.

A scan is a simple, non-invasive test that uses low-dose X-rays to measure the amount of calcium in plaque on the walls of the arteries of the heart.

"While we found that CAC scoring is accurate at predicting the risk of death over a 15-year period in all patients, this is the first study to show it is most accurate in those without a of early ," says Joseph Knapper, MD, an internal medicine resident at Emory University School of Medicine.

"This suggests there may be a benefit to expanding CAC testing to all low-risk patients, regardless of their family history, allowing patients to learn about their risks sooner and take actions to decrease them."

Current guidelines only recommend CAC scoring for low-risk patients if they have a family history of early heart disease.

Knapper and his colleagues followed 6,300 patients with a family history of early heart disease, and about 2,800 patients without a history. Each study participant underwent a CT scan to receive a CAC score and was interviewed to establish their risk factors for heart disease (i.e. cigarette smoking, , diabetes, etc.). Researchers tracked the patients for 15 years and recorded deaths that occurred in that time period, regardless of the cause.

They found that patients with a higher CAC score were more likely to have died over the 15-year period, even after controlling for other such as smoking and high blood pressure. Most importantly, the highest risk CAC scores (greater than 1,000) showed a nearly eight times higher risk of death compared to the lowest risk score in without a family history, whereas in those with a family history the risk was increased less than four-fold.

Knapper says further research, including cost analysis, is needed before a recommendation could be made to expand CAC screening guidelines.

Explore further: Study demonstrates need to change scoring system for heart disease

Related Stories

Study demonstrates need to change scoring system for heart disease

January 13, 2014
A study led by researchers at the University of California, San Diego School of Medicine shows that one of the most widely used systems for predicting risk of adverse heart events should be re-evaluated. A surprise finding ...

Coronary artery calcium predicts cardio death in T2DM

January 18, 2013
(HealthDay)—In addition to traditional cardiovascular disease risk factors, in patients with type 2 diabetes, coronary artery calcium (CAC) predicts the risk of cardiovascular death, according to a study published online ...

Greater density of coronary artery calcium associated with lower risk of CHD, CVD

November 18, 2013
Michael H. Criqui, M.D., M.P.H., of the University of California, San Diego, and colleagues determined the independent associations of coronary artery calcium (CAC) volume and CAC density with cardiovascular disease events. ...

Study shows value of calcium scan in predicting heart attack, stroke among those considered at risk

December 23, 2013
A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person's risk ...

Study shows heart calcium scan predictive of diabetes-related death from cardiovascular disease

December 20, 2012
People with Type 2 diabetes have two to four times the risk of cardiovascular disease compared to people without the disease. The best way for doctors to predict which diabetes patients are at the greatest risk for heart ...

Heart scans only useful in prescribing statins under certain conditions

March 13, 2014
(Medical Xpress)—As long as inexpensive statins, which lower cholesterol, are readily available and patients don't mind taking them, it doesn't make sense to do a heart scan to measure how much plaque has built up in a ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.